Catalyst Wire Dossier Catalyst Wire Dossier

Stiolto

tiotropium/olodaterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Stiolto, covering 2020-04-16 to 2023-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)

See pricing